Post-instrumentation Pain After Use of the Fanta and M3 Pro Gold Systems

NCT ID: NCT06382545

Last Updated: 2024-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-01

Study Completion Date

2022-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparing the intensity of post-operative pain following endodontic treatment of posterior teeth with Fanta (Pepsi gold) (FPG) and M3-pro+ Gold (assorted) (MPG) rotary files.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endodontic Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

20 participants treated with Fanta (Pepsi gold) (FPG)

aged 20 to 50 years

Group Type EXPERIMENTAL

Fanta (Pepsi gold) (FPG)

Intervention Type PROCEDURE

endodontic treatment of posterior teeth with Fanta (Pepsi gold) (FPG)

20 participants treated with M3-pro+ Gold (assorted) (MPG) rotary files

aged 20 to 50 years

Group Type EXPERIMENTAL

M3-pro+ Gold (assorted) (MPG)

Intervention Type PROCEDURE

endodontic treatment of posterior teeth with M3-pro+ Gold (assorted) (MPG) rotary files.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fanta (Pepsi gold) (FPG)

endodontic treatment of posterior teeth with Fanta (Pepsi gold) (FPG)

Intervention Type PROCEDURE

M3-pro+ Gold (assorted) (MPG)

endodontic treatment of posterior teeth with M3-pro+ Gold (assorted) (MPG) rotary files.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20-50 years old
* No systemic diseases
* Mandibular first molar
* Asymptomatic tooth
* Normal periapical film
* Restorable teeth
* Periodontal scoring index \<2

Exclusion Criteria

* Age \<20 and \>50
* Systemic disorders
* Articaine Allergy
* Inability to take paracetamol.
* Pregnancy or Nursing
* Symptomatic pulpitis.
* Pulp necrosis
* PDL is widening.
* Periapical radiolucency
* The sinus tract
* Periapical abscesses.
* Existence of resorption
* Tooth malposition.
* Fixed partial dentures.
* Analgesics intake in the last 12 hours.
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ahram Canadian University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Faten Mohamed Ahmed Ghonimy

Assisstany Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Faten Ghonimy

Role: STUDY_DIRECTOR

Ahram Canadian University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Oral and Dental medicine, Ahram Canadian University

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Approval number 36.3.22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.